B E Hedlund1, P E Hallaway. Show Affiliations » 1. Biomedical Frontiers, Inc., Minneapolis, MN 55414.
Abstract
Entities: Chemical
Mesh： See more » AnimalsDeferoxamine/therapeutic useDogsIron/metabolismIron Chelating Agents/therapeutic useMyocardial Ischemia/metabolismMyocardial Reperfusion Injury/drug therapyMyocardial Reperfusion Injury/metabolismRats
Substances： See more » Iron Chelating AgentsIronDeferoxamine
Year: 1993 PMID： 8359492 DOI： 10.1042/bst0210340
Source DB: PubMed Journal: Biochem Soc Trans ISSN： 0300-5127 Impact factor: 5.407